Sahyadri margin reaches 19.5% as integration rollout advances

Sahyadri Hospitals lifted its EBITDA margin to 19.5% in Q2 FY27 from 17.5% in Q1 FY27, alongside the rollout of centralized procurement rates, the addition of 83 clinicians and 11% digital revenue contribution. For H1 FY27, Sahyadri reported revenue of Rs 707 crore and EBITDA of Rs 131 crore.

What changed in Sahyadri's Q2 FY27 EBITDA margin?

Sahyadri's EBITDA margin increased by 200 basis points to 19.5% in Q2 FY27 from 17.5% in Q1 FY27. The sequential gain placed its H1 FY27 margin at 18.5%, based on revenue of Rs 707 crore and EBITDA of Rs 131 crore for the half year.

Sahyadri reported Q2 revenue growth of 13% over Q1 and Q2 EBITDA growth of 26% over Q1. The faster reported EBITDA growth than revenue growth coincided with the margin increase, although the presentation does not quantify the contribution of procurement, clinical or digital initiatives to the change.

For H1 FY27, revenue rose 17.8% versus H1 FY26 and EBITDA rose 24.1% versus the same period. The source notes that the H1 FY26 comparison follows erstwhile management reporting because Sahyadri was acquired on October 3, 2025, which qualifies the comparability of the prior-period figures.

How did Sahyadri perform in H1 FY27?

Sahyadri generated Rs 707 crore of revenue and Rs 131 crore of EBITDA in H1 FY27, producing an EBITDA margin of 18.5%. Revenue increased 17.8% and EBITDA increased 24.1% against H1 FY26 under the erstwhile management reporting basis disclosed by the presentation.

Occupancy was 67.0% in H1 FY27, 270 basis points above H1 FY26, while average revenue per occupied bed, or ARPOB, was Rs 44,100 a day, up 12.5%. The reported revenue increase therefore occurred alongside both higher bed utilisation and higher revenue per occupied bed.

The source does not disclose separate Q1 and Q2 occupancy or ARPOB for Sahyadri. It does disclose that Q2 revenue was 13% higher than Q1 and Q2 EBITDA was 26% higher, while the margin moved from 17.5% to 19.5% across the two quarters.

Which Sahyadri integration actions have been implemented?

Sahyadri has rolled out centralized procurement rates as its stated procurement-synergy action. The update does not disclose the spend categories covered, a procurement-cost baseline, savings achieved or a rupee target linked to the H1 FY27 EBITDA of Rs 131 crore.

On clinical talent, Sahyadri reported 83 clinician additions and interoperability involving 58 clinicians. Management said these measures are intended to enhance clinical capability and programmes, but it did not provide specialty-wise staffing, associated patient volumes or a subsequent hiring target.

Sahyadri also continued key digital revenue initiatives and neighbourhood outreach programmes. Digital revenue contributed 11% of Sahyadri revenue in the reported update, but no prior-period digital contribution was provided, preventing a disclosed comparison of its growth or change in mix.

What do Sahyadri's operating metrics indicate?

Sahyadri's H1 FY27 operating data show occupancy at 67.0% and ARPOB at Rs 44,100 a day, compared with an occupancy increase of 270 basis points and ARPOB growth of 12.5% versus H1 FY26. These measures provide operating context for the 17.8% H1 revenue increase to Rs 707 crore.

The quarterly data point to a higher reported pace in Q2 FY27 than Q1 FY27. Revenue rose 13% quarter on quarter, EBITDA rose 26%, and margin expanded 200 basis points to 19.5%, although the presentation does not provide a cost-line breakdown for Sahyadri itself.

The wider Maharashtra and Goa region reported Q2 FY27 occupancy of 69.8%, compared with 65.5% in Q2 FY26, while operational beds rose to 1,751 from 352. Those regional figures cover hospital operations and are reported separately from Sahyadri's H1 metrics, so they are not a direct Sahyadri comparison.

When will Sahyadri be rebranded?

Sahyadri has initiated a phased brand-transition process with a stated Q4 FY27 timeline. The update says the process will include engagement with government agencies, indicating that the planned transition includes administrative work in addition to branding activity.

The presentation displays the Sahyadri Hospitals and Manipal Hospitals brands together, but does not identify individual hospital sites, phase dates or approvals required before Q4 FY27. It also does not disclose a rebranding budget, revenue target or expected margin effect despite reporting an 11% digital revenue contribution.

The stated Q4 FY27 timetable is the clearest future integration milestone in the update. Management has not disclosed whether centralized procurement rates, the 83 clinician additions or the 58 clinician interoperability arrangements will have further specified phases before the brand transition.

Conclusion

Sahyadri's reported performance combines H1 FY27 revenue of Rs 707 crore, EBITDA of Rs 131 crore and an 18.5% margin with a Q2 margin of 19.5%, up from 17.5% in Q1. Centralized procurement rates, 83 clinician additions, 58 clinician interoperability arrangements and 11% digital revenue contribution show that multiple integration workstreams were active during the reported period.

The next disclosed milestone is the phased Q4 FY27 brand transition, which includes engagement with government agencies. Investors will need subsequent disclosures to assess whether Sahyadri quantifies procurement benefits, updates digital revenue contribution, reports the transition's progress and provides comparable operating data after the 67.0% H1 FY27 occupancy and Rs 44,100 daily ARPOB.